NCT02255383

Brief Summary

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for commercially available Persona fixed bearing knee implants used in total knee arthroplasty. The assessment will include implant survivorship and clinical performance.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
737

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Jul 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

14 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jul 2014Dec 2027

Study Start

First participant enrolled

July 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 2, 2014

Completed
11.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Expected
Last Updated

March 10, 2026

Status Verified

November 1, 2024

Enrollment Period

11.4 years

First QC Date

September 29, 2014

Last Update Submit

March 6, 2026

Conditions

Keywords

OsteoarthritisRheumatoid ArthritisTraumatic ArthritisPolyarthritisTotal Knee Arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Knee Society Score

    Knee Society Score

    10 years

Secondary Outcomes (1)

  • EQ-5D

    10 years

Study Arms (1)

PERSONA TKA

OTHER

Primary total knee arthroplasty subjects that receive the Zimmer Persona Total Knee System

Device: Zimmer Persona Total Knee System

Interventions

Primary Total Knee Arthroplasty

Also known as: Total Knee Arthroplasty, Total Knee Replacement
PERSONA TKA

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient 18-75 years of age, inclusive
  • Patient qualifies for primary total knee arthroplasty based on physical exam and medical history, including diagnosis of severe knee pain and disability due to at least one of the following: a) rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis; b) collagen disorders and/or avascular necrosis of the femoral condyle; c) post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy; d) moderate valgus, varus, or flexion deformities; or e) the salvage of previously failed surgical attempts that did not include partial or total knee arthroplasty of the ipsilateral knee
  • Patient has participated in a study-related Informed Consent process
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent Form
  • Patient is willing and able to complete scheduled study procedures and follow-up evaluations
  • Independent of study participation, patient is a candidate for commercially available Persona fixed bearing knee components implanted in accordance with product labeling

You may not qualify if:

  • Patient is currently participating in any other surgical intervention studies or pain management studies
  • Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint
  • Insufficient bone stock on femoral or tibial surfaces
  • Skeletal immaturity
  • Neuropathic arthropathy
  • Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
  • Stable, painless arthrodesis in a satisfactory functional position
  • Severe instability secondary to the absence of collateral ligament integrity
  • Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  • Patient has a known or suspected sensitivity or allergy to one or more of the implant materials
  • Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)
  • Patient has previously received partial or total knee arthroplasty for the ipsilateral knee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Colorado Joint Replacement

Denver, Colorado, 80210, United States

Location

Orthopaedic & Spine Center of the Rockies

Fort Collins, Colorado, 80525, United States

Location

Denver-Vail Orthopedics

Parker, Colorado, 80134, United States

Location

Rockford Orthopedic Associates

Rockford, Illinois, 61114, United States

Location

Henry County Orthopedics and Sports Medicine

New Castle, Indiana, 47362, United States

Location

UNC Department of Orthopaedics

Chapel Hill, North Carolina, 27599-7055, United States

Location

OrthoCarolina

Charlotte, North Carolina, 28207, United States

Location

Raleigh Orthopaedic Clinic

Raleigh, North Carolina, 27612, United States

Location

Lindner Research Center

Cincinnati, Ohio, 45219, United States

Location

SportsMedicine Grant & Orthopaedic Associates

Columbus, Ohio, 43215, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Tennessee Orthopaedic Foundation for Education and Research

Knoxville, Tennessee, 37930, United States

Location

Texas Tech University Health Sciences Center

Lubbock, Texas, 79430, United States

Location

Jordan Young Institute

Virginia Beach, Virginia, 23462-1784, United States

Location

MeSH Terms

Conditions

OsteoarthritisArthritis, RheumatoidArthritisGenu Valgum

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBone Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2014

First Posted

October 2, 2014

Study Start

July 1, 2014

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2027

Last Updated

March 10, 2026

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations